Abstract

In the context of kidney transplantation, little is known about the involvement of natural killer (NK) cells in the immune reaction leading to either rejection or immunological tolerance under immunosuppression. Therefore, the peripheral NK cell repertoire of patients after kidney transplantation was investigated in order to identify NK cell subsets that may be associated with the individual immune status at the time of their protocol biopsies for histopathological evaluation of the graft. Alterations in the peripheral NK cell repertoire could be correlated to the type of immunosuppression, i.e., calcineurin-inhibitors like Cyclosporin A vs. Tacrolimus with or without addition of mTOR inhibitors. Here, we could demonstrate that the NK cell repertoire in peripheral blood of kidney transplant patients differs significantly from healthy individuals. The presence of donor-specific antibodies was associated with reduced numbers of CD56dim NK cells. Moreover, in patients, down-modulation of CD16 and CD6 on CD56dim NK cells was observed with significant differences between Cyclosporin A- and Tac-treated patients. Tac-treatment was associated with decreased CD69, HLA-DR, and increased CD94/NKG2A expression in CD56dim NK cells indicating that the quality of the immunosuppressive treatment impinges on the peripheral NK cell repertoire. In vitro studies with peripheral blood mononuclear cells of healthy donors showed that this modulation of CD16, CD6, CD69, and HLA-DR could also be induced experimentally. The presence of calcineurin or mTOR inhibitors had also functional consequences regarding degranulation and interferon-γ-production against K562 target cells, respectively. In summary, we postulate that the NK cell composition in peripheral blood of kidney transplanted patients represents an important hallmark of the efficacy of immunosuppression and may be even informative for the immune status after transplantation in terms of rejection vs. drug-induced allograft tolerance. Thus, NK cells can serve as sensors for immunosuppression and may be utilized for future strategies of an individualized adjustment of immunosuppression.

Highlights

  • Human natural killer (NK) cells are part of the innate immune system and play a critical role in the host defense against pathogens and tumor cells by their cytotoxic potential and the production of cytokines and chemokines

  • In order to identify an influence of donor-specific antibodies (DSA) and the immunosuppressive regimen on NK cells in kidney transplanted patients, the number and subset distribution of NK cells were analyzed in 120 kidney recipients (KTx) at 12 months (n = 34) after transplantation

  • For the determination of NK cell numbers per μl, the Trucount staining procedure was performed in which NK cells are marked by CD56 PE and CD16 PE antibodies in combination with T and B cell markers

Read more

Summary

Introduction

Human natural killer (NK) cells are part of the innate immune system and play a critical role in the host defense against pathogens and tumor cells by their cytotoxic potential and the production of cytokines and chemokines. The markers include the Fcγ-receptor IIIa (CD16), CD6 (Braun et al, 2011), and KIR (killer cell immunoglobulin-like receptors) which are expressed on the majority of CD56dim cells. In contrast to the CD56dim subset, CD56bright NK cells express CD16 and CD6 at very low levels of less than 3% but display a higher density of the inhibitory heterodimer CD94/NKG2A (Yu et al, 2010). Other surface receptors such as the activation-dependent markers CD25, CD69, HLA-DR, and typical NK cell receptors like the natural cytotoxicity receptors (NCR), NKG2D, and CD161 are expressed on both subsets. In addition to the distinct phenotypic features, the two NK cell subsets are associated www.frontiersin.org

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.